Senior insider sale
See Remarks at ROCKET PHARMACEUTICALS, INC. — senior position signals high conviction
$196.4K
63.22K shares
What this filing means
SHAH GAURAV plans to sell 63.22K shares of ROCKET PHARMACEUTICALS, INC. valued at approximately $196.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/18/2026ACC: 0001959173-26-006169
DirectorOfficer· See Remarks
Since Jan 2019
63.22K
Shares to sell
$196.4K
Approx. market value
2.29K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
8/14/2026
2.29KTotal acquired2.29K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/14/2026 | Restricted Stock Vesting Compensation | 2.29K | — |
| Total | 2.29K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
2.84K
Market value
$9.6K
8/13/2026
—Completed
Units to sell
55.68K
Market value
$171.8K
5/21/2026
—Completed
Units to sell
2.41K
Market value
$7.3K
5/19/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
2.29K
Market value
$7.8K
8/18/2026
Total
Units
63.22K
Value
$196.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/13/2026 | 2.84K | $9.6K | — | Completed |
5/21/2026 | 55.68K | $171.8K | — | Completed |
5/19/2026 | 2.41K | $7.3K | — | Completed |
| Planned — Approximate Date | ||||
8/18/2026 | 2.29K | $7.8K | NASDAQ | Planned |
| Total | 63.22K | $196.4K | ||